Remove 2029 Remove Healthcare Remove Safety
article thumbnail

Digitalisation of the clinical trial landscape

European Pharmaceutical Review

According to Maximize Market Research , new technologies are expected to boost the clinical trials market between 2022 to 2029, especially as the industry and patients are shifting towards digitalisation approaches and personalised medicines.

Safety 111
article thumbnail

Emerging Trends in Orthopedic Medical Device Industry

Medico Reach

What really matters are the orthopedic medical device trends that are already shaping the healthcare industry. Advancements in medical technology will always be a favorite topic of discussion when analyzing the healthcare sector. billion by 2029. Healthcare executives are also looking into AR spinal surgical systems.

Medical 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Emerging Trends in Orthopedic Medical Device Industry

Medico Reach

What really matters are the orthopedic medical device trends that are already shaping the healthcare industry. Advancements in medical technology will always be a favorite topic of discussion when analyzing the healthcare sector. billion by 2029. Healthcare executives are also looking into AR spinal surgical systems.

Medical 52
article thumbnail

Antibody-drug conjugates: paving the future of oncology clinical development

European Pharmaceutical Review

Yet as the market continues to recognise the value of these treatments, especially with them having “clear benefits over current monotherapy and combination therapy options in cancer treatment”, it is unsurprising that GlobalData’s research predicted the ADC oncology therapy market will value more than $36 billion by 2029.

Patients 105
article thumbnail

Key Developments from AMCP 2023 on Blockbuster Generics, Diabetes Drugs, PBM Legislation, and More

PM360

Under the pathway, manufacturers can use safety and efficacy data from existing products in their applications for their own products. This increases to 15 Part D drugs in 2026, as well as 15 Part B and D drugs in 2028, and a full 20 Part B and D drugs in 2029. Starting in 2026, the provision will affect 10 Part D drugs.

article thumbnail

Accurate dosing: How to achieve maximum precision with poor-flowing products

Pharmaceutical Technology

Due to rising healthcare spending, launch of novel treatments, and the rise of chronic diseases in an aging population, the global pharmaceutical packaging equipment market is rapidly expanding. billion by 2029, registering a CAGR of over 8% during the forecast period of 2022-2029. Recent analysis valued the market [i] at USD 8.5